About Benchmarks:

Are you ready for this regulation? Use this benchmark to find out. Each benchmark is build directly for the federal regulation.  They reflect the learning objectives of the related course. The benchmark is not a "trivia test" - they help you evaluate your readiness to apply the new regulation. Contact us for more information and/or personalized benchmarks for your specific organization/industry.

Benchmark: Mandatory Guidelines for Federal Workplace Drug Testing Programs Using Urine (UrMG): Proposed Revisions

Take this benchmark to assess how much you would benefit from taking the course on Proposed Revisions to the Mandatory Guidelines for Federal Workplace Drug Testing Programs Using Urine (UrMG). In 5–7 minutes, you’ll test your grasp of the rule’s intent, practical impacts, and the trade-offs behind the changes.

What you’ll get:

  • A quick read on whether you understand why the revisions matter (clarity, consistency, scientific rigor, and efficiency)
  • Signals on operational readiness: QC changes, observed collection staffing, biomarker flexibility, ECCF adoption, and panel updates
  • Insight on who is affected (agencies, labs, collectors, MROs, donors) and where friction or risk might show up
  • Guidance on whether—and how—you should engage in public comment to shape the final rule
  • A shortlist of topics to prioritize in SOPs, contracts, and training if you move forward with the course

How this helps: Benchmarks are taken before the course to highlight knowledge gaps and focus your learning. If the questions feel hard or raise “it depends” scenarios, that’s a sign the full course will save you time, reduce compliance risk, and help you make smarter implementation decisions.

NOTE: Unless otherwise indicated, all Benchmarks are free of charge!

Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Mandatory Guidelines for Federal Workplace Drug Testing Programs Using Urine (UrMG). Document Number: 2026-22122

Buy this Course
FR-26-3288-1